Surgical glue is made of two components contained in separate vials; a freeze dried concentrate of clotting proteins, mainly fibrinogen, Factor XIII and fibronectin (the sealant) and freeze dried thrombin (the catalyst). The first component is reconstituted with an aprotinin solution that inhibits tissue fibrinolysis. The second component (thrombin) is dissolved with calcium chloride that is available in 500 I. U. concentration. Indications for the use of human fibrin sealant are numerous and present in all surgical branches. It is also effective in preventing local hemorrhagic complications after inguinal hernia repair in patients with concurrent coagulation disorders.
The global surgical glue market is anticipated to show significant market growth during the forecast period, owing to increase in geriatric population, increase in number of surgical procedures performed, and increase in incidence of wounds and injuries. Furthermore, increase in number of road accidents, increase in awareness regarding surgical glue and increase in prevalence of chronic diseases are considerably contributing toward the market growth. However, high cost of surgical glues and availability of alternate products and unpopularity of minimally invasive surgeries are negatively impacting the market growth. Conversely, the high growth potential in emerging countries offers lucrative opportunities for growth of the market.
The global surgical glue market is segmented on the basis of product, application, end user, and region. By product, the market is classified into natural and synthetic & semi-synthetic. By application, it is classified into central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries, and others. By end user, it is classified into hospitals, ambulatory surgery centers, and others. Region wise, the market is studied across North America (U. S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).
Major companies profiled in the report include Artivion, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Integra Lifesciences Corporation, Johnson & Johnson, Medtronic plc, Ocular Therapeutix Inc., and OptMed, Inc.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the surgical glue market analysis from 2021 to 2031 to identify the prevailing surgical glue market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the surgical glue market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global surgical glue market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By End user
- Hospitals
- Ambulatory Surgical Centers
- Others
By Product
- Natural
- Synthetic and Semi Synthetic
By Application
- Central Nervous System Surgeries
- General Surgeries
- Cardiovascular Surgeries
- Orthopedic Surgeries
- Cosmetic Surgeries
- Ophthalmic Surgeries
- Urological Surgeries
- Pulmonary Surgeries
- Others
By Region
- North America
- U. S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Baxter International Inc.
- B. Braun Melsungen AG
- Cohera Medical, Inc.
- CryoLife Inc.
- CSL Limited
- Johnson & Johnson
- Ocular Therapeutix Inc.
- Sanofi
- Sealantis Ltd.
- Vivostat
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: SURGICAL GLUE MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Natural
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Synthetic and Semi Synthetic
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
CHAPTER 5: SURGICAL GLUE MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Central Nervous System Surgeries
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 General Surgeries
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
5.4 Cardiovascular Surgeries
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market share analysis by country
5.5 Orthopedic Surgeries
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market share analysis by country
5.6 Cosmetic Surgeries
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market share analysis by country
5.7 Ophthalmic Surgeries
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market share analysis by country
5.8 Urological Surgeries
5.8.1 Key market trends, growth factors and opportunities
5.8.2 Market size and forecast, by region
5.8.3 Market share analysis by country
5.9 Pulmonary Surgeries
5.9.1 Key market trends, growth factors and opportunities
5.9.2 Market size and forecast, by region
5.9.3 Market share analysis by country
6.0 Others
6.0.1 Key market trends, growth factors and opportunities
6.0.2 Market size and forecast, by region
6.0.3 Market share analysis by country
CHAPTER 6: SURGICAL GLUE MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3 Ambulatory Surgical Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market share analysis by country
CHAPTER 7: SURGICAL GLUE MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End user
7.2.5 North America Market size and forecast, by country
7.2.5.1 U. S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Product
7.2.5.1.3 Market size and forecast, by Application
7.2.5.1.4 Market size and forecast, by End user
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Product
7.2.5.2.3 Market size and forecast, by Application
7.2.5.2.4 Market size and forecast, by End user
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Product
7.2.5.3.3 Market size and forecast, by Application
7.2.5.3.4 Market size and forecast, by End user
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End user
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Product
7.3.5.1.3 Market size and forecast, by Application
7.3.5.1.4 Market size and forecast, by End user
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Product
7.3.5.2.3 Market size and forecast, by Application
7.3.5.2.4 Market size and forecast, by End user
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Product
7.3.5.3.3 Market size and forecast, by Application
7.3.5.3.4 Market size and forecast, by End user
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Product
7.3.5.4.3 Market size and forecast, by Application
7.3.5.4.4 Market size and forecast, by End user
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Product
7.3.5.5.3 Market size and forecast, by Application
7.3.5.5.4 Market size and forecast, by End user
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Product
7.3.5.6.3 Market size and forecast, by Application
7.3.5.6.4 Market size and forecast, by End user
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End user
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Product
7.4.5.1.3 Market size and forecast, by Application
7.4.5.1.4 Market size and forecast, by End user
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Product
7.4.5.2.3 Market size and forecast, by Application
7.4.5.2.4 Market size and forecast, by End user
7.4.5.3 India
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Product
7.4.5.3.3 Market size and forecast, by Application
7.4.5.3.4 Market size and forecast, by End user
7.4.5.4 Australia
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Product
7.4.5.4.3 Market size and forecast, by Application
7.4.5.4.4 Market size and forecast, by End user
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Product
7.4.5.5.3 Market size and forecast, by Application
7.4.5.5.4 Market size and forecast, by End user
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Product
7.4.5.6.3 Market size and forecast, by Application
7.4.5.6.4 Market size and forecast, by End user
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End user
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Product
7.5.5.1.3 Market size and forecast, by Application
7.5.5.1.4 Market size and forecast, by End user
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Product
7.5.5.2.3 Market size and forecast, by Application
7.5.5.2.4 Market size and forecast, by End user
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Product
7.5.5.3.3 Market size and forecast, by Application
7.5.5.3.4 Market size and forecast, by End user
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Product
7.5.5.4.3 Market size and forecast, by Application
7.5.5.4.4 Market size and forecast, by End user
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Baxter International Inc.
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 B. Braun Melsungen AG
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Cohera Medical, Inc.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 CryoLife Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 CSL Limited
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Johnson & Johnson
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Ocular Therapeutix Inc.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Sanofi
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Sealantis Ltd.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Vivostat
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
Executive Summary
According to this report, titled, 'Surgical Glue Market,' the surgical glue market was valued at $2.3 billion in 2021 and is estimated to reach $4.6 billion by 2031, growing at a CAGR of 7% from 2022 to 2031.Skin glue is a special medical glue used to close wounds. It can be used on its own or with stitches or adhesive tape. It forms a protective waterproof covering over your wound. Skin glue is usually used for cuts or wounds that are small or minor and up to 5cm long. They should have straight edges that can be easily pulled together. Skin glue is often used to close wounds on the face or head and some parts of the arms and legs. It also includes the trunk of the body (torso). Skin glue is not suitable for wounds over joints, such as knees or hands. Skin glue is applied as a liquid or paste to edges of a wound. It takes only a few minutes to set. The glue usually forms a scab that peels or falls off in 5 to 10 days. The scar generally takes about 6 months to fade. It is mainly used to close both major and minor wounds, such as lacerations, incisions made during laparoscopic surgery, and wounds on the face or in the groin. The benefits of surgical glue include its lower rates of infection, less time in the operating room, less scarring feature, no need for needle sticks or stitches, which also makes it child friendly and helps people to quickly return to work and other activities, such as sports. Surgical glue costs more than sutures. Some people are allergic to it. The glue cannot be used if patient has an increased risk of slow wound healing which occurs in diabetes and other health conditions.
By product, the synthetic & semi-synthetic segment is anticipated to grow with the largest Surgical Glue Market Size during the Surgical Glue Market Analysis period. This is attributed to advancements in Surgical Glue Industry increase in use of surgical glue-based on synthetic and semi-synthetic components in healthcare institutions such as hospitals. Recent advances in Surgical Glue Industry have contributed toward improvement in preference for glues, thus driving the market growth. On the other side, the natural segment is projected to exhibit the fastest market growth during the forecast period, owing to increased demand for surgical glues in ambulatory surgical centers and increase in prevalence of chronic diseases.
By application, the cardiovascular surgeries segment acquired major Surgical Glue Market Size in 2021, and is anticipated to continue this trend during the forecast period, owing to increase in incidences of wound & sports injuries and increase in geriatric population as they are more prone to chronic diseases. In addition, the central nervous system surgeries segment is expected to exhibit the fastest market growth during the forecast period due to higher incidence of wounds from road accidents, burns, and other injury conditions.
By end user, the hospitals segment acquired the largest Surgical Glue Market Share in 2021, and is anticipated to continue this trend during the forecast period. This is attributed to increase in number of hospitals globally and rise in number of hospital visits for the surgeries to be performed. On the other side, the others segment is projected to exhibit the fastest market growth during the Surgical Glue Market Forecast period, owing to increase in preference of healthcare professionals for using surgical glues in hospitals for patients in wound care management.
North America accounted for the largest Surgical Glue Market Share of revenue in 2021, and is anticipated to maintain its dominance from 2022 to 2031, owing to Surgical Glue Market Trends such as presence of large patient population, strong presence of key players, ease of product availability, well developed healthcare infrastructure, higher number of research, development, and innovative activities and higher adoption of advanced technologies. Moreover, Asia-Pacific is also expected to grow at the highest CAGR, owing to increase in number of accidents on regular basis and rise in awareness related to surgical glues for medical and surgical use.
Key findings of the study
By product, the synthetic and semi-synthetic segment accounted for major share of the global surgical glue market in 2021.
By application, the central nervous system surgeries segment is anticipated to grow with the highest CAGR during the forecast period.
By end user, the hospitals segment is anticipated to grow with the highest CAGR during the forecast period.
By region, Asia-Pacific is anticipated to grow at the highest rate during the analysis period.
Companies Mentioned
- Baxter International Inc.
- B. Braun Melsungen AG
- Cohera Medical, Inc.
- Cryolife Inc.
- Csl Limited
- Johnson & Johnson
- Ocular Therapeutix Inc.
- Sanofi
- Sealantis Ltd.
- Vivostat
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 290 |
Published | October 2022 |
Forecast Period | 2021 - 2031 |
Estimated Market Value ( USD | $ 2340.71 million |
Forecasted Market Value ( USD | $ 4614.85 million |
Compound Annual Growth Rate | 7.0% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |